Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2355 studies found for:    ADULT SYNDROME
Show Display Options
Rank Status Study
21 Completed Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)
Condition: Respiratory Distress Syndrome, Adult
Interventions: Behavioral: Minimal (Trophic) Feeding;   Behavioral: Full Feeding
22 Terminated Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)
Condition: Respiratory Distress Syndrome, Adult
Interventions: Behavioral: Minimal (Trophic) Feeding;   Behavioral: Full Feeding;   Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements;   Dietary Supplement: Placebo
23 Active, not recruiting Natural History of Amyloid Deposition in Adults With Down Syndrome
Condition: Down Syndrome
Intervention:
24 Terminated Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
Condition: Tourette's Syndrome
Interventions: Drug: PF-03654746;   Drug: Placebo
25 Completed Open-Trial of EPI-743 for Adults With Tourette Syndrome
Condition: Tourette Syndrome
Intervention: Drug: EPI-743
26 Active, not recruiting Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)
Condition: Down Syndrome
Interventions: Behavioral: Verbal instructions with picture diagram;   Behavioral: Verbal instructions with video of ADSC;   Behavioral: verbal instructions w. video of w/o DS;   Behavioral: verbal instructions w. video w/DS
27 Completed Adaptation Among Adolescents and Adults With Klinefelter Syndrome
Condition: Klinefelter Syndrome
Intervention:
28 Suspended FAAH Inhibitor Trial for Adults With Tourette Syndrome
Condition: Tourette Syndrome
Interventions: Drug: PF-04457845;   Drug: Placebo
29 Withdrawn Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial
Condition: Metabolic Syndrome
Intervention: Behavioral: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count
30 Completed Evaluation of a Simplified Method for Diagnosis of Sleep Apnea in Children and Adults With Down Syndrome
Condition: Down Syndrome
Intervention: Other: Polysomnography
31 Completed Changes in Refractory Acute Respiratory Distress Syndrome (ARDS) Patients Under High Frequency Oscillation-ventilation
Condition: Respiratory Distress Syndrome, Adult
Intervention:
32 Completed Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: Methionine deficient diet;   Dietary Supplement: Methionine sufficient diet
33 Completed Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
Condition: Irritable Bowel Syndrome
Intervention:
34 Recruiting A Study in Adults With Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: OV101 Regimen 1;   Drug: OV101 regimen 2;   Other: Placebo
35 Completed Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: AFQ056;   Drug: Placebo
36 Completed A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: MG01CI extended-release tablet
37 Completed Hemodynamic Assessment With Trans-esophageal Doppler (TED) During Prone Ventilation in ARDS Patients
Condition: Respiratory Distress Syndrome, Adult
Intervention:
38 Completed A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)
Condition: Down Syndrome
Interventions: Drug: Placebo;   Drug: RG1662
39 Recruiting Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
Conditions: Adult Patients With Low Risk Myelodysplastic Syndrome;   Adult Patients With Int 1-risk Myelodysplastic Syndrome
Interventions: Drug: Erythropoietin alpha;   Drug: Deferasirox
40 Unknown  Growth Hormone Use in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Nutropin AQ

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.